Prime Medicine (PRME) Other Operating Expenses (2023)

Prime Medicine's (PRME) quarterly Other Operating Expenses came in at $13.5 million in Q4 2023.

Prime Medicine (PRME) Other Operating Expenses (2023) Analysis & Trends

Prime Medicine (PRME) has 1 years of Other Operating Expenses data on file, last reported at $13.5 million in Q4 2023.

Quarterly Other Operating Expenses changed N/A year-over-year to $13.5 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $13.5 million (changed N/A YoY) and the FY2023 annual result came in at $13.5 million, changed N/A from the prior year.
Other Operating Expenses was little changed at $13.5 million in Q4 2023.
In the past five years, Other Operating Expenses ranged from a high of $13.5 million in Q4 2023 to a low of $13.5 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Prime Medicine	558.48 Mn	558.48 Mn	-

Download Data

Date	Value
Dec 31, 2023	13.50 Mn